Search

Your search keyword '"Zureikat, Amer H."' showing total 1,155 results

Search Constraints

Start Over You searched for: Author "Zureikat, Amer H." Remove constraint Author: "Zureikat, Amer H."
1,155 results on '"Zureikat, Amer H."'

Search Results

301. Significance of Uncinate Duct Dilatation in IPMNs: A New High-risk Criterion?

303. Correction to: Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center

304. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

305. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development

306. Natural course of pain in chronic pancreatitis is independent of disease duration

309. ASO Visual Abstract: A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival

310. Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center

312. Correction to: Laparoscopic‑assisted ERCP following RYGB: a 12‑year assessment of outcomes and learning curve at a high‑volume pancreatobiliary center

313. Laparoscopic-assisted ERCP following RYGB: a 12-year assessment of outcomes and learning curve at a high-volume pancreatobiliary center

314. A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival

318. Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX.

319. Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy.

322. Groove pancreatitis has a spectrum of severity and can be managed conservatively

323. The histopathology of SPINK1-associated chronic pancreatitis

327. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy

328. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.

329. Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome.

330. Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences.

333. Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case–Control Matched Analysis

334. Significance of Uncinate Duct Dilatation in IPMNs

335. Formal robotic training diminishes the learning curve for robotic pancreatoduodenectomy: Implications for new programs in complex robotic surgery

337. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma

338. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy

340. The Fistula Risk Score Catalog

341. Association of Mentorship and a Formal Robotic Proficiency Skills Curriculum With Subsequent Generations’ Learning Curve and Safety for Robotic Pancreaticoduodenectomy

342. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome

343. A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients

344. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)

346. 100 PROACTIVE EUS-GUIDED FINE-NEEDLE ASPIRATION AND/OR BIOPSY (EUS-FNA/B) TISSUE COLLECTION IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) ALLOWS FOR COMPREHENSIVE GENOMIC PROFILING (CGP)

347. 664 PROACTIVE EUS-GUIDED FINE-NEEDLE ASPIRATION AND/OR BIOPSY (EUS-FNA/B) TISSUE COLLECTION IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) ALLOWS FOR COMPREHENSIVE GENOMIC PROFILING (CGP)

348. 105 TARGETED NEXT-GENERATION SEQUENCING (NGS) OF BILIARY BRUSHINGS AND BIOPSIES IMPROVES THE DETECTION OF MALIGNANT STRICTURES AND POTENTIALLY STRATIFIES PATIENTS FOR TARGETED ANTICANCER THERAPY

349. Sa1396 NEXT-GENERATION SEQUENCING OF PANCREATIC CYST FLUID IS BOTH SENSITIVE AND SPECIFIC FOR THE CLASSIFICATION OF NEOPLASTIC CYSTS AND THE DETECTION OF ADVANCED NEOPLASIA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS: A PROSPECTIVE MULTI-INSTITUTIONAL STUDY

350. 428 TARGETED NEXT-GENERATION SEQUENCING (NGS) OF BILIARY BRUSHINGS AND BIOPSIES IMPROVES THE DETECTION OF MALIGNANT STRICTURES AND POTENTIALLY STRATIFIES PATIENTS FOR TARGETED ANTICANCER THERAPY

Catalog

Books, media, physical & digital resources